Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)

3 years ago

Final draft guidance based on cost effectiveness evaluation of sotrovimabSAN FRANCISCO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc.…

Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions

3 years ago

DUBLIN, Ireland, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer…

Good Supply Cannabis Brand Launches Canada’s Strongest Infused Pre-Rolls

3 years ago

Introducing the New Good Supply MONSTERS™ Pre-Rolls Now Available Across CanadaTORONTO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc.…

Petalfast to Partner with Cannabis Lifestyle Brand Old Pal in California and Arizona

3 years ago

IRVINE, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Petalfast, a route-through-market platform for the cannabis industry, announced its sales and…

Catalyst Pharmaceuticals to Ring the Nasdaq Closing Bell in Honor of International Rare Disease Day

3 years ago

Spotlight On Raising Awareness for Rare Diseases on February 28, 2023 Celebrating the Tireless Contributions of Patients and Advocates who…

Tilray Brands Announces Issuance of Series A Preferred Stock

3 years ago

Goal is to Enhance Corporate Governance with Proposed Charter AmendmentNEW YORK and LEAMINGTON, Ontario, Feb. 22, 2023 (GLOBE NEWSWIRE) --…

Aquestive Therapeutics to Report Fourth Quarter 2022 Financial Results and Recent Business Highlights on March 7 and Host Conference Call on March 8 at 8:00 a.m. ET

3 years ago

WARREN, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the “Company” or “Aquestive”), a pharmaceutical company…

Eterna Therapeutics Enters Into Option and License Agreement with Lineage Cell Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications

3 years ago

CAMBRIDGE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna”), a preclinical-stage biotechnology company committed to…

VYNE Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference

3 years ago

BRIDGEWATER, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical…

SmileDirectClub Adds Innovative Sensitivity-Free Whitening Kit to Its Oral Care Portfolio

3 years ago

SmileDirectClub Sensitivity-Free Whitening Kit SmileDirectClub Sensitivity-Free Whitening Kit Latest advancement in teeth whitening provides gentle option for customerswith tooth sensitivityNASHVILLE,…